Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
The objective of this long-term observational study is to assess progression-free survival and overall survival of patients treated with at least 1 dose of study treatment (placebo or plerixafor) for a period of 5 years following the first dose of study treatment (placebo or plerixafor) in protocol AMD3100-3102.
Inclusion criteria
- Survival of multiple myeloma patients following autologous transplant in study AMD3100-3102